Literature DB >> 12820000

Giant-cell fibroblastoma in a patient with a bone-marrow transplant.

D Carroll1, P Ramani, A D Lander.   

Abstract

A case of an epigastric giant-cell fibroblastoma is reported in a 6-year-old girl who had undergone a bone-marrow transplant for severe combined immunodeficiency secondary to adenosine deaminase deficiency. A small subcutaneous nodule had been excised from the epigastrium at age 12 months.

Entities:  

Mesh:

Year:  2003        PMID: 12820000     DOI: 10.1007/s00383-002-0827-y

Source DB:  PubMed          Journal:  Pediatr Surg Int        ISSN: 0179-0358            Impact factor:   1.827


  5 in total

1.  Immunological surveillance in neoplasia.

Authors:  F M Burnet
Journal:  Transplant Rev       Date:  1971

2.  Giant cell fibroblastoma: a report of three cases.

Authors:  F W Abdul-Karim; H L Evans; E G Silva
Journal:  Am J Clin Pathol       Date:  1985-02       Impact factor: 2.493

3.  Giant cell fibroblastoma. A juvenile form of dermatofibrosarcoma protuberans.

Authors:  B M Shmookler; F M Enzinger; S W Weiss
Journal:  Cancer       Date:  1989-11-15       Impact factor: 6.860

4.  Giant cell fibroblastoma. A distinctive, recurrent tumor of childhood.

Authors:  R B Dymock; P W Allen; J W Stirling; E F Gilbert; J M Thornbery
Journal:  Am J Surg Pathol       Date:  1987-04       Impact factor: 6.394

5.  Giant cell fibroblastoma of soft tissue: a clinicopathological and immunohistochemical study.

Authors:  C D Fletcher
Journal:  Histopathology       Date:  1988-11       Impact factor: 5.087

  5 in total
  2 in total

1.  Multicentric dermatofibrosarcoma protuberans in patients with adenosine deaminase-deficient severe combined immune deficiency.

Authors:  Chimene Kesserwan; Robert Sokolic; Edward W Cowen; Elizabeth Garabedian; Kerstin Heselmeyer-Haddad; Chyi-Chia Richard Lee; Stefania Pittaluga; Clarymar Ortiz; Kristin Baird; Dolores Lopez-Terrada; Julia Bridge; Alan S Wayne; Fabio Candotti
Journal:  J Allergy Clin Immunol       Date:  2011-12-06       Impact factor: 10.793

2.  Long-Term Outcome of Adenosine Deaminase-Deficient Patients-a Single-Center Experience.

Authors:  Ori Scott; Vy Hong-Diep Kim; Brenda Reid; Anne Pham-Huy; Adelle R Atkinson; Alessandro Aiuti; Eyal Grunebaum
Journal:  J Clin Immunol       Date:  2017-07-26       Impact factor: 8.542

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.